Motilal Oswal Alternates Invests $ 72 Mn in Hyderabad‑Based Medtech firm Sensa Core

The new capital infusion is expected to support product development and expand its footprint globally while strengthening its position as one of the leading players in the IVD segment.

Motilal Oswal Alternates has announced an INR 72 million investment in Sensa Core Medical Instrumentation, a Hyderabad‑based medtech company that designs and manufactures in‑vitro diagnostic (IVD) devices.

Founded in 2006 by Dr. Ravi Kumar Meruva, Sensa Core develops a range of diagnostic equipment, including electrolyte analysers, glucometers, haemoglobin meters, and arterial blood gas analysers.

The new capital infusion is expected to support product development and expand its footprint globally while strengthening its position as one of the leading players in the IVD segment.

Commenting on the new capital infusion, Dr. Ravi Kumar Meruva, Chairman & Founder, and now Managing Director of Sensa Core, said, “We are excited to enter the next phase of product innovation, advancing manufacturing automation while driving the conceptualization and execution of a diverse portfolio of point-of-care products. Built on deep expertise in electrochemistry and bio-analytical transducers, Sensa Core brings together industrial design, mechanical, electrical, electronics, software, and chemistry disciplines under one roof to create integrated, high-quality solutions.”

“With a strong focus on expanding access to healthcare, we believe affordability can be achieved through local manufacturing and large-scale production. The investment from Motilal Oswal Alternates reinforces confidence in our vision. Their commitment to supporting India-first companies with global ambition aligns strongly with our mission, and this partnership positions Sensa Core to evolve into a global institution of excellence,” he further added.

Further, the company’s products are reportedly used in more than 40,000 hospitals and diagnostic laboratories in India and are exported to over 78 countries.

Currently, the Company operates a dedicated manufacturing facility in Hyderabad’s Export Promotion Industrial Park, Pashamylara.

With the new investment, the company plans to commission a new manufacturing facility at the Medical Device Park in Sultanpur, Hyderabad, aimed at expanding production capacity and supporting the development of new products.

On this new partnership, Rohit Mantri, Managing Director and Co-Head of Private Equity at Motilal Oswal Alternates, said, “India imports over 75% of its medical devices, with annual imports exceeding USD 8.5 billion. We firmly believe in fostering indigenous development and manufacturing in India for local needs and for ‘Make in India’ exports to the world. Sensa Core exemplifies India’s new era of homegrown medical device champions, driven by rising demand for high-quality, affordable, and globally competitive products.”

“With this investment, Motilal Oswal Alternates continues to back high-quality companies in the life sciences space, especially R&D-led medical device innovators that are set to lead different categories worldwide,” he further added.

Stay tuned for more such updates on Digital Health News